Please login to the form below

Not currently logged in
Email:
Password:

human growth hormone

This page shows the latest human growth hormone news and features for those working in and with pharma, biotech and healthcare.

NICE recommends Novartis’ Piqray in combination with Faslodex for advanced breast cancer patients

NICE recommends Novartis’ Piqray in combination with Faslodex for advanced breast cancer patients

Around 2, 800 specific breast cancer patients in England and Wales could benefit from the treatment, including postmenopausal women, and men, with hormone receptor positive (HR+), human epidermal growth factor receptor

Latest news

More from news
Approximately 1 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • Implementing eHealth innovation Implementing eHealth innovation

    Medications management and eHealth. The reference treatment for patients with GHD is based on recombinant human growth hormone (rhGH) which is identical to the growth hormone produced by the pituitary gland. ... growth hormone deficiency, one in which

  • Pharma deals during December 2014 Pharma deals during December 2014

    costs. Pfizer has also signed up to a drug delivery product this month through its $570m licensing deal with Opko Health for a long acting version of human growth hormone (hGH), ... which is currently in phase III trials for the treatment of growth

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To transform lives through communication that changes behaviour and improves health outcomes....

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...